Developer docs
API playgroundTry for free, no card

Search company profiles

ACM Global

Full company profile

uuid000bcvx

Namestring
ACM Global
Legal namestring
ACM Medical Laboratory, Inc. dba ACM Global Laboratories
Company typeenum
Private
Founded yearint
1975
Descriptiontext

ACM Global Laboratories (legal entity ACM Medical Laboratory, Inc. dba ACM Global Laboratories) is a privately held, US-domiciled clinical trial central laboratory founded in 1975 and headquartered in Rochester, New York, with 501–1000 employees and an affiliation with Rochester Regional Health. The company provides central laboratory testing services to pharmaceutical and biotechnology sponsors running clinical trials in 65+ countries, supported by wholly-owned facilities in Rochester (US), York (UK), Singapore, and Mumbai (India), plus a partner laboratory network. Its service portfolio is organized into three lines: Bioanalytical Services (PK bioanalysis, large molecule bioanalysis, pharmacodynamic biomarker analysis, controlled substance analysis, novel drug delivery systems, nicotine research, cannabinoid testing), Central Lab Services (clinical trial testing, biomarker testing, flow cytometry, radiopharmaceutical, routine safety testing, pathology, customized sample collection kits, advanced sample tracking), and Toxicology Services delivered through the wholly-owned DRUGSCAN brand (drug monitoring, workplace testing, reference lab testing).

ACM's underlying technology centers on a harmonized laboratory platform deployed across global sites for consistency in chemistry, hematology, urinalysis, flow cytometry, and immunology testing, wrapped by proprietary client-facing tools: LabStar (single-database data management across global locations), ACM QuikReport™ (real-time client reporting portal), and Advanced Sample Tracking Services for specimen chain-of-custody. Regulatory credentials include CAP accreditation (notably at the Singapore hub) and compliance with CAP/CLIA, GDPR, and the EU-U.S. Data Privacy Framework.

The business model is professional services / contract-based B2B: each clinical trial program is customized to protocol, with pricing quoted per engagement rather than published. Go-to-market is enterprise field sales targeting pharma/biotech sponsors directly, supplemented by a DRUGSCAN franchise selling toxicology and medication monitoring to healthcare providers. The company is privately held with no disclosed funding rounds or external investors, and is affiliated with (rather than owned by) Rochester Regional Health.

Short descriptiontext

ACM Global Laboratories is a privately held, US-headquartered central laboratory founded in 1975, providing customized clinical trial testing, bioanalytical, and toxicology (DRUGSCAN) services to pharmaceutical and biotech sponsors across 65+ countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
501–1,000
akta.pro rankint
HeadquartersRochester, United States
HQ citystring
Rochester
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices5 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical laboratory services, central lab testing, bioanalytical services, toxicology testing, contract research organization
Industry5 codes
PRIMARYHLAGAAAE
Central Laboratory & Clinical Trial Testing CROs
SECONDARYHLAGAEAA
Central Laboratory Services (Core Lab Operations)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
SECONDARYHLAFAMAJ
Reference & Esoteric Testing Laboratories
SECONDARYHLAAAMAC
Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays)
Healthcare & Life Sciences/Biotechnology & Biologics/Biomarkers and Companion Diagnostics
SECONDARYHLAGAEAG
Bioanalytical & PK/PD Sample Analysis (Trial Support)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
NAICS code2 codes
  • Medical Laboratories621511
  • Scientific Research and Development Services5417
SIC code2 codes
  • Services-Medical Laboratories8071
  • Services-Commercial Physical & Biological Research8731
Product category
Clinical Laboratory Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Central Laboratory Testing Services
TypeProfessional Services
Description

ACM Global Laboratories provides central lab services for clinical trial programs, including routine and esoteric testing, bioanalytical services, biomarker testing, flow cytometry, pathology, and radiopharmaceutical services. Services are customized per clinical trial program and billed on a project/contract basis.

acmgloballab.com
2Bioanalytical Services
TypeProfessional Services
Description

Comprehensive bioanalytical testing including PK bioanalysis, large molecule bioanalysis, pharmacodynamic biomarker analysis, controlled substance analysis, novel drug delivery systems, nicotine research, and cannabinoid testing for drug development programs.

acmgloballab.com
3Toxicology Services (DRUGSCAN)
TypeProfessional Services
Description

Toxicology laboratory testing services including drug monitoring, workplace testing, and reference laboratory testing, delivered through the DRUGSCAN brand with a 30-year track record in medication monitoring solutions.

acmgloballab.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 7 records shown
1DRUGSCAN
Description

Best-in-breed toxicology laboratory testing company with 30-year track record delivering innovative medication monitoring solutions to healthcare providers across the United States

acmgloballab.com
+6 more records
Core offering1 text field

ACM Global Laboratories provides customized central laboratory testing services for clinical trial programs, including routine and esoteric safety testing, biomarker analysis, flow cytometry, pathology, radiopharmaceutical testing, and bioanalytical services such as PK analysis, large molecule bioanalysis, and pharmacodynamic biomarker assessment. Toxicology and drug monitoring services are delivered through the DRUGSCAN brand, with proprietary platforms (LabStar and ACM QuikReport) enabling seamless global data management.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

ACM Global Laboratories is a global clinical trial testing services company offering three interconnected service lines: (1) Bioanalytical Services including ACM Bioanalysis, Large Molecule Bioanalysis, Advanced PK/Pharmacokinetic Services, Pharmacodynamic Biomarker Analysis, Controlled Substance Analysis, Novel Drug Delivery Systems, Nicotine Research, and Cannabinoid Testing; (2) Central Lab Services encompassing Clinical Trial Testing, Rescue Studies, Expedite Studies, Biomarker Testing, Flow Cytometry Testing, Radiopharmaceutical Services, Routine Safety Testing, Customized Sample Collection Kits, Advanced Sample Tracking Services, COVID-19 Research Studies, and Pathology Services; and (3) Toxicology Services through the acquired DRUGSCAN brand covering Drug Monitoring, Workplace Testing, and Reference Laboratory Testing. Client-facing platforms include LabStar and ACM QuikReport for reporting and portal access. The company operates wholly-owned facilities in the United States (Rochester, NY), Europe (York, UK), Singapore, and India (Mumbai), supporting clinical trials in more than 65 countries.

Product and service3 records
1ACM Central Lab Services
CategoryCentral Laboratory Services
Description

Provides customized central laboratory services for clinical trial programs, including routine safety testing, biomarker testing, flow cytometry, pathology, radiopharmaceutical services, customized sample collection kits, and advanced sample tracking, with scientific experts and project managers helping sponsors make data-driven decisions from inception to completion.

2ACM Bioanalysis
CategoryBioanalytical Services
Description

Provides assay method development and validation for the quantification of drugs, metabolites, and biomarkers in biological samples, supporting PK bioanalysis, large molecule bioanalysis, pharmacodynamic biomarker analysis, controlled substance analysis, novel drug delivery systems, nicotine research, and cannabinoid testing for drug development programs.

3DRUGSCAN (Toxicology Services)
CategoryToxicology Services
Description

Toxicology laboratory testing services for healthcare providers, including drug monitoring, workplace drug testing, and reference laboratory testing, delivered through the DRUGSCAN brand with a 30-year track record in medication monitoring solutions.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeOthers
Description

DRUGSCAN is a best-in-breed toxicology laboratory testing company with a 30-year track record of delivering innovative medication monitoring solutions to healthcare providers across the United States. ACM Global Laboratories includes DRUGSCAN under its Toxicology Services umbrella, offering drug monitoring, workplace testing, and reference laboratory testing services.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Worldwide Clinical Trials is a mid-sized global CRO with central laboratory and bioanalytical capabilities, competing with ACM for mid-sized pharma and biotech central lab programs.

TypeBroad incumbent
Description

Charles River is a large CRO and lab services provider offering central lab, bioanalytical, and safety assessment services across a broader discovery-to-clinical continuum that overlaps with ACM's trial support work.

TypeDirect peer
Description

Eurofins Central Laboratory provides global central lab and specialty testing services for clinical trials, with a comparable multi-region footprint and routine/specialty testing menu.

TypeEmerging player
Description

BioAgilytix is a bioanalytical-focused lab with large molecule and biomarker capabilities serving clinical trials, partially overlapping with ACM's ACM Bioanalysis and biomarker service lines.

TypeBroad incumbent
Description

IQVIA operates the world's largest CRO platform and includes significant central lab capabilities through Q² Solutions and bioanalytical services, competing with ACM across multiple service lines.

TypeDirect peer
Description

ICON plc runs a global central laboratory network serving clinical trials with bioanalytical, biomarker, and specialty testing services that closely mirror ACM Global's offerings.

TypeDirect peer
Description

Q² Solutions is a leading clinical trial central laboratory services joint venture between IQVIA and Quest Diagnostics, offering end-to-end central lab, bioanalytical, and biomarker services comparable to ACM's portfolio.

TypeDirect peer
Description

Fortrea (spun out of Labcorp) is one of the largest global central laboratory and clinical trial services providers, directly competing with ACM Global Laboratories for multi-region Phase II/III central lab contracts.

TypeDirect peer
Description

Medpace operates a global central laboratory with bioanalytical and biomarker services supporting its CRO business, offering a comparable mid-sized full-service model to ACM.

TypeBroad incumbent
Description

PPD, part of Thermo Fisher Scientific, is a global CRO with central laboratory services and bioanalytical capabilities that compete with ACM on large multi-region clinical trial programs.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

ACM Global

Clinical Laboratory Servicesacmgloballab.com

ACM Global Laboratories is a privately held, US-headquartered central laboratory founded in 1975, providing customized clinical trial testing, bioanalytical, and toxicology (DRUGSCAN) services to pharmaceutical and biotech sponsors across 65+ countries.

What ACM Global does

ACM Global Laboratories (legal entity ACM Medical Laboratory, Inc. dba ACM Global Laboratories) is a privately held, US-domiciled clinical trial central laboratory founded in 1975 and headquartered in Rochester, New York, with 501–1000 employees and an affiliation with Rochester Regional Health. The company provides central laboratory testing services to pharmaceutical and biotechnology sponsors running clinical trials in 65+ countries, supported by wholly-owned facilities in Rochester (US), York (UK), Singapore, and Mumbai (India), plus a partner laboratory network. Its service portfolio is organized into three lines: Bioanalytical Services (PK bioanalysis, large molecule bioanalysis, pharmacodynamic biomarker analysis, controlled substance analysis, novel drug delivery systems, nicotine research, cannabinoid testing), Central Lab Services (clinical trial testing, biomarker testing, flow cytometry, radiopharmaceutical, routine safety testing, pathology, customized sample collection kits, advanced sample tracking), and Toxicology Services delivered through the wholly-owned DRUGSCAN brand (drug monitoring, workplace testing, reference lab testing).

ACM's underlying technology centers on a harmonized laboratory platform deployed across global sites for consistency in chemistry, hematology, urinalysis, flow cytometry, and immunology testing, wrapped by proprietary client-facing tools: LabStar (single-database data management across global locations), ACM QuikReport™ (real-time client reporting portal), and Advanced Sample Tracking Services for specimen chain-of-custody. Regulatory credentials include CAP accreditation (notably at the Singapore hub) and compliance with CAP/CLIA, GDPR, and the EU-U.S. Data Privacy Framework.

The business model is professional services / contract-based B2B: each clinical trial program is customized to protocol, with pricing quoted per engagement rather than published. Go-to-market is enterprise field sales targeting pharma/biotech sponsors directly, supplemented by a DRUGSCAN franchise selling toxicology and medication monitoring to healthcare providers. The company is privately held with no disclosed funding rounds or external investors, and is affiliated with (rather than owned by) Rochester Regional Health.

ACM Global firmographics

Firmographics
Name
ACM Global
Legal name
ACM Medical Laboratory, Inc. dba ACM Global Laboratories
Website
https://acmgloballab.com
Company type
Private
Founded year
1975
Operating status
Operating
Headcount range
501–1,000 employees
Short description
ACM Global Laboratories is a privately held, US-headquartered central laboratory founded in 1975, providing customized clinical trial testing, bioanalytical, and toxicology (DRUGSCAN) services to pharmaceutical and biotech sponsors across 65+ countries.
Ownership category
akta.pro rank

ACM Global industry classification

Industry
Product category
Clinical Laboratory Services
NAICS
Medical Laboratories (621511), Scientific Research and Development Services (5417)
SIC
Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGAAAE
Central Laboratory & Clinical Trial Testing CROs
SECONDARYHLAGAEAA
Central Laboratory Services (Core Lab Operations)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
SECONDARYHLAFAMAJ
Reference & Esoteric Testing Laboratories
SECONDARYHLAAAMAC
Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays)
Healthcare & Life Sciences/Biotechnology & Biologics/Biomarkers and Companion Diagnostics
SECONDARYHLAGAEAG
Bioanalytical & PK/PD Sample Analysis (Trial Support)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)

Keywords

  • Clinical laboratory services
  • Central lab testing
  • Bioanalytical services
  • Toxicology testing
  • Contract research organization

Where ACM Global is headquartered

Location

Headquarters

HQ city
Rochester
HQ country
United States
HQ region
North America

Offices5 records

Markets served

ACM Global business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

  1. Central Laboratory Testing Services: ACM Global Laboratories provides central lab services for clinical trial programs, including routine and esoteric testing, bioanalytical services, biomarker testing, flow cytometry, pathology, and radiopharmaceutical services. Services are customized per clinical trial program and billed on a project/contract basis.
  2. Bioanalytical Services: Comprehensive bioanalytical testing including PK bioanalysis, large molecule bioanalysis, pharmacodynamic biomarker analysis, controlled substance analysis, novel drug delivery systems, nicotine research, and cannabinoid testing for drug development programs.
  3. Toxicology Services (DRUGSCAN): Toxicology laboratory testing services including drug monitoring, workplace testing, and reference laboratory testing, delivered through the DRUGSCAN brand with a 30-year track record in medication monitoring solutions.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

ACM Global product offering

Product offering

Core offering

ACM Global Laboratories provides customized central laboratory testing services for clinical trial programs, including routine and esoteric safety testing, biomarker analysis, flow cytometry, pathology, radiopharmaceutical testing, and bioanalytical services such as PK analysis, large molecule bioanalysis, and pharmacodynamic biomarker assessment. Toxicology and drug monitoring services are delivered through the DRUGSCAN brand, with proprietary platforms (LabStar and ACM QuikReport) enabling seamless global data management.

Product overview

ACM Global Laboratories is a global clinical trial testing services company offering three interconnected service lines: (1) Bioanalytical Services including ACM Bioanalysis, Large Molecule Bioanalysis, Advanced PK/Pharmacokinetic Services, Pharmacodynamic Biomarker Analysis, Controlled Substance Analysis, Novel Drug Delivery Systems, Nicotine Research, and Cannabinoid Testing; (2) Central Lab Services encompassing Clinical Trial Testing, Rescue Studies, Expedite Studies, Biomarker Testing, Flow Cytometry Testing, Radiopharmaceutical Services, Routine Safety Testing, Customized Sample Collection Kits, Advanced Sample Tracking Services, COVID-19 Research Studies, and Pathology Services; and (3) Toxicology Services through the acquired DRUGSCAN brand covering Drug Monitoring, Workplace Testing, and Reference Laboratory Testing. Client-facing platforms include LabStar and ACM QuikReport for reporting and portal access. The company operates wholly-owned facilities in the United States (Rochester, NY), Europe (York, UK), Singapore, and India (Mumbai), supporting clinical trials in more than 65 countries.

Differentiator

Problem solved

Functional benefit

Brands

  • DRUGSCAN: Best-in-breed toxicology laboratory testing company with 30-year track record delivering innovative medication monitoring solutions to healthcare providers across the United States
  • DSI Medical
  • ACM Bioanalysis
  • ACM Central Lab Services
  • ACM Toxicology Services
  • ACM QuikReport
  • LabStar

Products and services

  • ACM Central Lab Services Provides customized central laboratory services for clinical trial programs, including routine safety testing, biomarker testing, flow cytometry, pathology, radiopharmaceutical services, customized sample collection kits, and advanced sample tracking, with scientific experts and project managers helping sponsors make data-driven decisions from inception to completion.
  • ACM Bioanalysis Provides assay method development and validation for the quantification of drugs, metabolites, and biomarkers in biological samples, supporting PK bioanalysis, large molecule bioanalysis, pharmacodynamic biomarker analysis, controlled substance analysis, novel drug delivery systems, nicotine research, and cannabinoid testing for drug development programs.
  • DRUGSCAN (Toxicology Services) Toxicology laboratory testing services for healthcare providers, including drug monitoring, workplace drug testing, and reference laboratory testing, delivered through the DRUGSCAN brand with a 30-year track record in medication monitoring solutions.

Companies that use ACM Global

Customer profile

Segments2 records

Ideal customer profiles2 records

ACM Global technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature7 records

ACM Global partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • DRUGSCANcoreOthersDRUGSCAN is a best-in-breed toxicology laboratory testing company with a 30-year track record of delivering innovative medication monitoring solutions to healthcare providers across the United States. ACM Global Laboratories includes DRUGSCAN under its Toxicology Services umbrella, offering drug monitoring, workplace testing, and reference laboratory testing services.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

ACM Global competitors and assessment

Company assessment

Direct peers

  • Worldwide Clinical Trials: Worldwide Clinical Trials is a mid-sized global CRO with central laboratory and bioanalytical capabilities, competing with ACM for mid-sized pharma and biotech central lab programs.
  • Eurofins Central Laboratory: Eurofins Central Laboratory provides global central lab and specialty testing services for clinical trials, with a comparable multi-region footprint and routine/specialty testing menu.
  • ICON Central Laboratories: ICON plc runs a global central laboratory network serving clinical trials with bioanalytical, biomarker, and specialty testing services that closely mirror ACM Global's offerings.
  • Q² Solutions: Q² Solutions is a leading clinical trial central laboratory services joint venture between IQVIA and Quest Diagnostics, offering end-to-end central lab, bioanalytical, and biomarker services comparable to ACM's portfolio.
  • Labcorp Central Laboratories (Fortrea): Fortrea (spun out of Labcorp) is one of the largest global central laboratory and clinical trial services providers, directly competing with ACM Global Laboratories for multi-region Phase II/III central lab contracts.
  • Medpace Reference Laboratories: Medpace operates a global central laboratory with bioanalytical and biomarker services supporting its CRO business, offering a comparable mid-sized full-service model to ACM.

Broad incumbents

  • Charles River Laboratories: Charles River is a large CRO and lab services provider offering central lab, bioanalytical, and safety assessment services across a broader discovery-to-clinical continuum that overlaps with ACM's trial support work.
  • IQVIA Laboratories: IQVIA operates the world's largest CRO platform and includes significant central lab capabilities through Q² Solutions and bioanalytical services, competing with ACM across multiple service lines.
  • PPD Central Laboratory (Thermo Fisher): PPD, part of Thermo Fisher Scientific, is a global CRO with central laboratory services and bioanalytical capabilities that compete with ACM on large multi-region clinical trial programs.

Emerging players

  • BioAgilytix Labs: BioAgilytix is a bioanalytical-focused lab with large molecule and biomarker capabilities serving clinical trials, partially overlapping with ACM's ACM Bioanalysis and biomarker service lines.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

ACM Global social profiles

Digital presence

ACM Global financial estimates

Financial estimate

Revenue estimate

Valuation estimate

ACM Global leadership team

Management profile

Number of profiles

Profiles1 record

ACM Global subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

ACM Global funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

ACM Global M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ACM Global

What does ACM Global do?

ACM Global Laboratories provides customized central laboratory testing services for clinical trial programs, including routine and esoteric safety testing, biomarker analysis, flow cytometry, pathology, radiopharmaceutical testing, and bioanalytical services such as PK analysis, large molecule bioanalysis, and pharmacodynamic biomarker assessment. Toxicology and drug monitoring services are delivered through the DRUGSCAN brand, with proprietary platforms (LabStar and ACM QuikReport) enabling seamless global data management.

Is ACM Global a public or private company?

ACM Global is a private company. It is classified as unknown and is currently operating.

When was ACM Global founded?

ACM Global was founded in 1975. It employs 501 to 1,000 people.

Where is ACM Global based?

ACM Global is headquartered in Rochester, United States, in the North America region.

How does ACM Global make money?

Three revenue lines are on record. Central Laboratory Testing Services are the primary driver. The others are bioanalytical Services and toxicology Services (DRUGSCAN).

Who are ACM Global's main competitors?

Direct peers on record are Worldwide Clinical Trials, Eurofins Central Laboratory, ICON Central Laboratories, Q² Solutions, Labcorp Central Laboratories (Fortrea) and Medpace Reference Laboratories. Broad incumbents are Charles River Laboratories, IQVIA Laboratories and PPD Central Laboratory (Thermo Fisher). BioAgilytix Labs is listed as an emerging player.

Does ACM Global have an API?

No public API is recorded for ACM Global.

What industry is ACM Global in?

ACM Global's product category is Clinical Laboratory Services. Its primary akta.pro industry code is HLAGAAAE, Central Laboratory & Clinical Trial Testing CROs, with a secondary code of HLAGAEAA, Central Laboratory Services (Core Lab Operations). Its NAICS code is 621511 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
openPR.comBiostatistics Consulting Service Market Top Companies Study - IQVIA Parexel are Charles River, ACM Global, Celerion, Clinitude.InsightAce Analytic released a market assessment report on the global biostatistics consulting service market, projecting a CAGR of 10.6% from 2024 to 2031. North America is expected to hold the largest share, while Asia-Pacific is projected to see the fastest growth. The report also lists key players including IQVIA, Parexel, and Charles River.TfscroThe Benefits of Central Laboratory Services for Clinical Trials - TFS HealthScienceThe central laboratory services market for clinical trials is projected to reach $5.05 billion by 2030, driven by the industry's shift toward outsourcing approximately 80% of lab work to third-party vendors like Labcorp and ACM Global Laboratories. These centralized providers enhance trial accuracy and efficiency by standardizing testing procedures, ensuring regulatory compliance, and managing complex logistics compared to local site laboratories.AcmgloballabClinical Trials and Central Lab ServicesACM Global Laboratories is a provider of central lab and clinical trial services that has been operating since 1975 with facilities in over 65 countries. The company offers bioanalytical, toxicology, and drug monitoring solutions to support global drug development programs.Business Wire BlogACM Global Laboratories Announces Strategic Acquisition of DrugScan and DSI Medical Services Growing International Laboratory BusinessACM Global Laboratories, a subsidiary of Rochester Regional Health, acquired DrugScan and DSI Medical Services, expanding its toxicology and drug testing capabilities. The acquisition, completed December 31, 2017, adds to ACM's global lab network across 65 countries. ACM expects continued growth in the toxicology market as health systems combat the opioid epidemic.